Gofen & Glossberg LLC Bristol Myers Squibb CO Transaction History

Gofen & Glossberg LLC

$3.89 Billion
Q4 2022

A detailed history of Gofen & Glossberg LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gofen & Glossberg LLC holds 94,923 shares of BMY stock, worth $4.66 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

94,923

Previous 97,775 2.92%

Holding current value

$4.66 Million

Previous $6.95 Million 1.74%

% of portfolio

0.18%

Previous 0.2%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	SELL	$68.48 - $81.09 $195,304 - $231,268	-2,852 Reduced 2.92%	94,923 $6.83 Million
Q3 2022 Oct 13, 2022	BUY	$0.13 - $76.84 $22 - $13,370	174 Added 0.18%	97,775 $6.95 Million
Q2 2022 Jul 14, 2022	SELL	$72.62 - $79.98 $40,812 - $44,948	-562 Reduced 0.57%	97,601 $7.52 Million
Q1 2022 Apr 14, 2022	SELL	$61.48 - $73.72 $201,654 - $241,801	-3,280 Reduced 3.23%	98,163 $7.17 Million
Q4 2021 Jan 25, 2022	SELL	$53.63 - $62.52 $2.25 Million - $2.62 Million	-41,905 Reduced 29.23%	101,443 $6.33 Million
Q3 2021 Oct 13, 2021	SELL	$59.17 - $69.31 $153,782 - $180,136	-2,599 Reduced 1.78%	143,348 $8.48 Million
Q2 2021 Jul 13, 2021	SELL	$61.91 - $67.42 $892,866 - $972,331	-14,422 Reduced 8.99%	145,947 $9.75 Million
Q1 2021 Apr 13, 2021	SELL	$59.34 - $66.74 $1.18 Million - $1.33 Million	-19,937 Reduced 11.06%	160,369 $10.1 Million
Q4 2020 Jan 15, 2021	SELL	$57.74 - $65.43 $235,983 - $267,412	-4,087 Reduced 2.22%	180,306 $11.2 Million
Q3 2020 Oct 09, 2020	BUY	$57.43 - $63.64 $518,535 - $574,605	9,029 Added 5.15%	184,393 $11.1 Million
Q2 2020 Jul 13, 2020	BUY	$54.82 - $64.09 $373,817 - $437,029	6,819 Added 4.05%	175,364 $10.3 Million
Q1 2020 Apr 14, 2020	SELL	$46.4 - $67.43 $406,464 - $590,686	-8,760 Reduced 4.94%	168,545 $9.4 Million
Q4 2019 Jan 28, 2020	BUY	$49.21 - $64.19 $6.8 Million - $8.87 Million	138,128 Added 352.57%	177,305 $11.4 Million
Q3 2019 Oct 10, 2019	SELL	$42.77 - $50.71 $47,859 - $56,744	-1,119 Reduced 2.78%	39,177 $1.99 Million
Q2 2019 Jul 12, 2019	SELL	$44.62 - $49.34 $38,908 - $43,024	-872 Reduced 2.12%	40,296 $1.83 Million
Q1 2019 Apr 11, 2019	SELL	$45.12 - $53.8 $26,620 - $31,742	-590 Reduced 1.41%	41,168 $1.96 Million
Q4 2018 Jan 15, 2019	SELL	$48.76 - $63.23 $30,475 - $39,518	-625 Reduced 1.47%	41,758 $2.17 Million
Q3 2018 Oct 11, 2018	SELL	$55.19 - $62.25 $54,582 - $61,565	-989 Reduced 2.28%	42,383 $2.63 Million
Q2 2018 Jul 11, 2018	SELL	$50.53 - $62.98 $16,169 - $20,153	-320 Reduced 0.73%	43,372 $2.4 Million
Q1 2018 Apr 11, 2018	SELL	$59.92 - $68.98 $76,697 - $88,294	-1,280 Reduced 2.85%	43,692 $2.76 Million
Q4 2017 Jan 11, 2018	SELL	$59.94 - $65.35 $43,576 - $47,509	-727 Reduced 1.59%	44,972 $2.76 Million
Q3 2017 Nov 16, 2017	SELL	$55.23 - $63.74 $6,793 - $7,840	-123 Reduced 0.27%	45,699 $2.91 Million
Q2 2017 Aug 16, 2017	BUY	N/A	45,822	45,822 $2.55 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $104B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.

Account

Gofen & Glossberg LLC Bristol Myers Squibb CO Transaction History